Agenus Investor Relations Material
Latest events
Q2 2024
Agenus
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Agenus Inc
Access all reports
Agenus Inc. helps in the discovery and development of immuno-oncology products worldwide. The company’s platform is a combination of software that enables researchers to promote immune responses against cancer and corresponding drug discovery tools. Agenus Inc. was founded in 1994 and is based in Lexington, Massachusetts.
Latest articles
Cristiano Amon: Qualcomm's 5G Specialist CEO
Cristiano Amon, Qualcomm CEO, has spent two decades at the company while taking on several roles, developing both technical and business expertise.
16 Sep 2024
Qualcomm: Quality Communication and Semiconductor Innovation
Founded in 1985, Qualcomm has transformed the digital communication industry with CDMA technology and its advanced semiconductor business.
13 Sep 2024
Strong Opinions, Loosely Held: Pontus Dackmo on Flexibility and Market Psychology
After a two-decade career in finance, Pontus Dackmo co-founded Protean Funds Scandinavia in 2022, where he now serves as CEO and Investment Manager.
4 Sep 2024
Ticker symbol
AGEN
Country
🇺🇸 United States